Table 4.
Meta-analysis of postbronchodilator FEV1,/FVC ratio including interactions for age and atopy and age and diagnosis
Model 1 |
Model 2 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Variables | Estimates | Confidence (95%) | limits | P value* | I 2 | P value (heterogeneity)† | Estimates | Confidence (95%) | limits | P value* | I 2 | P value (heterogeneity)† |
Age/year from 20 (years) | −0.250 | −0.291 | −0.209 | <0.001 | 37.8 | 0.058 | −0.241 | −0.274 | −0.207 | <0.001 | 39.3 | 0.049 |
Sex | ||||||||||||
Female | – | – | – | – | – | – | – | – | – | – | – | – |
Male | 0.062 | −0.806 | 0.929 | 0.889 | 4.2 | 0.405 | −0.192 | −1.024 | 0.640 | 0.651 | 0.0 | 0.721 |
Height/m | −0.097 | −0.145 | −0.050 | <0.001 | 15.4 | 0.273 | −0.088 | −0.134 | −0.042 | <0.001 | 12.5 | 0.307 |
Cases grouping | ||||||||||||
Controls (ref) | – | – | – | – | – | – | – | – | – | – | – | – |
Asthmatic | −4.001 | −5.018 | −2.984 | <0.001 | 27.3 | 0.143 | −0.128 | −1.508 | 1.252 | 0.856 | 0.0 | 0.948 |
Sinusitis | −0.307 | −1.229 | 0.614 | 0.513 | 4.2 | 0.406 | −1.231 | −3.980 | 1.518 | 0.380 | 55.4 | 0.004 |
Both Asthma & Sinusitis | −2.942 | −4.070 | −1.815 | <0.001 | 10.1 | 0.335 | −3.413 | −9.937 | 3.111 | 0.305 | 87.4 | <0.001 |
Age*case interaction | ||||||||||||
Controls (ref) | – | – | – | – | – | – | ||||||
Asthmatic*Age | −0.135 | −0.186 | −0.084 | <0.001 | 0.0 | 0.658 | ||||||
Sinusitis*Age | 0.030 | −0.063 | 0.122 | 0.529 | 52.8 | 0.006 | ||||||
Both Asthma & Sinusitis*Age | −0.003 | −0.233 | 0.228 | 0.982 | 85.5 | <0.001 | ||||||
Smoking (per pack year) | −0.086 | −0.123 | −0.049 | <0.001 | 50.5 | 0.009 | −0.084 | −0.120 | −0.048 | <0.001 | 42.9 | 0.031 |
Smoking status | ||||||||||||
Never (ref) | – | – | – | – | – | – | – | – | – | – | – | – |
Former | −0.439 | −1.710 | 0.832 | 0.498 | 60.0 | 0.001 | −0.457 | −1.731 | 0.818 | 0.482 | 59.8 | 0.001 |
Current | −1.971 | −2.971 | −0.970 | <0.001 | 0.0 | 0.518 | −2.235 | −3.238 | −1.231 | <0.001 | 0.4 | 0.449 |
Atopy | ||||||||||||
No Atopy (ref) | – | – | – | – | – | – | ||||||
Atopy | 0.996 | −0.326 | 2.318 | 0.140 | 6.1 | 0.385 | ||||||
Atopy*Age | −0.034 | −0.083 | 0.014 | 0.166 | 17.8 | 0.260 |
Atopy was considered positive if ≥3 mm reaction size to any of the allergens.
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
Effect Estimate.
Heterogeneity of effects between centers.